Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 76,239 | 68,861 | 51,196 | 36,833 | 20,683 |
| Operating Income | -76,239 | -68,861 | -51,196 | -36,833 | -20,683 |
| Other Income | 4,970 | 4,396 | 13,511 | 6,196 | -10,986 |
| Pre-tax Income | -71,269 | -64,465 | -37,685 | -30,637 | -31,669 |
| Net Income Continuous | -71,269 | -64,465 | -37,685 | -30,637 | -31,669 |
| Net Income | $-71,269 | $-64,465 | $-37,685 | $-30,637 | $-31,669 |
| EPS Basic Total Ops | -4.89 | -6.18 | -10.33 | -26.90 | -51.70 |
| EPS Basic Continuous Ops | -4.89 | -6.18 | -10.33 | -26.89 | -51.70 |
| EPS Diluted Total Ops | -4.89 | -6.18 | -10.33 | -26.90 | -51.70 |
| EPS Diluted Continuous Ops | -4.89 | -6.18 | -10.33 | -26.89 | -51.70 |
| EPS Diluted Before Non-Recurring Items | -4.89 | -6.18 | -10.30 | -32.40 | N/A |
| EBITDA(a) | $-74,866 | $-67,753 | $-50,221 | $-36,456 | $-20,683 |